Risk of skin reactions when using ibuprofen-based medicines

Expert Opinion on Drug Safety

Volumn 4, Issue 5, 2005, Pages 837-848

  Sánchez Borges, Mario ^a,b   Capriles Hulett, Arnaldo ^a   Caballero Fonseca, Fernan ^a  

^a Centro Medico Docente La Trinidad   (Venezuela)

^b Clinica El Avila   (Venezuela)

Author keywords

Cutaneous drug reaction; Hypersensitivity; Ibuprofen; Nonsteroidal anti inflammatory drug (NSAID); Propionic acid derivative

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CHOLINE; DIFLUNISAL; ETODOLAC; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MECLOFENAMIC ACID; MELOXICAM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OLSALAZINE; OXAPROZIN; PARACETAMOL; PENICILLIN DERIVATIVE; PROPIONIC ACID DERIVATIVE; SALAZOSULFAPYRIDINE; SALICYLATE SODIUM; SULINDAC; TIAPROFENIC ACID; TOLMETIN; UNINDEXED DRUG; ZAFIRLUKAST;

ALLERGIC VASCULITIS; AMBLYOPIA; ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARTHRALGIA; BILE DUCT DISEASE; BULLOUS DERMATITIS; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONSULTATION; CONTACT DERMATITIS; COST OF ILLNESS; COUGHING; DEHYDRATION; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG ERUPTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG USE; DYSPNEA; ECZEMA; EDEMA; EPIGASTRIC PAIN; ERYTHEMA MULTIFORME; EYELID DISEASE; FACE EDEMA; FEVER; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; KIDNEY DISEASE; LEUKOCYTOCLASTIC VASCULITIS; LICHENOID ERUPTION; LIP DISEASE; LIVEDO RETICULARIS; MALAISE; MEDICAL LITERATURE; MORBIDITY; MYALGIA; NAUSEA; NOSE OBSTRUCTION; OSTEOARTHRITIS; PEMPHIGOID; PHOTODERMATOSIS; PREVALENCE; PUBLISHING; PURPURA; PUSTULOSIS; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SATIETY; SKIN ALLERGY; SKIN ANAPHYLAXIS; SKIN BLEEDING; SKIN MANIFESTATION; SKIN NECROSIS; SNEEZING; STEVENS JOHNSON SYNDROME; SUBCUTANEOUS NODULE; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS; VISUAL IMPAIRMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; DRUG ERUPTIONS; ECONOMICS, PHARMACEUTICAL; HUMANS; IBUPROFEN;

EID: 24344498371     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.4.5.837     Document Type: Review

References (63)

1. WARNER TD, MITCHELL JA: Cyclooxygenase-3 (COX-3): Filling in the gap towards a COX continuum? Proc. Natl. Acad. Sci. USA (2002) 99(21):13371-13373.
2. LAUNEVILLE O, BREWER DK, DE WITT DL: Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Pharm. Exp. Ther. (1994) 271:927-934.
3. SPILVA A, MUKTANS Y: Guía de las especialidades farmacéuticas. XXVIIIth edition, Caracas 2004/2005.
4. IMS HEALTH MAT, January 2005.
5. LAZAROU J, POMERANZ BH, COREY PN: Incidence of adverse drug reactions in hospitalizad patients. A meta-analysis of prospective studies. J. Am. Med. Assoc. (1998) 279(15):1200-1205.
6. POUYANNE P, HARAMBURU F, IMBS JL, BEGAUD D: Admissions to hospital caused by adverse drug reactions: Cross sectional incidence study. Br. Med. J. (2000) 320(7241):1036.
7. CLASSEN DC, PESTOTNIK SL, EVANS RS, BURKE JP: Computarized surveillance of adverse drug events in hospital patients. J. Am. Med. Assoc. (1991) 266(20):2847-2851.
8. BATES DW, CULLEN DJ, LAIRD N: Incidence of adverse drug events and potential adverse drug events. J. Am. Med. Assoc. (1995) 274(1):29-34.
9. IMPICCIATORE P, CHOONARA I, CLARKSON A, PROVASI D, PANDOLFINI C, BONATI M: Incidence of adverse drug reactions in paediatric in/outpatients: A systematic review and meta-analysis of prospective studies. Br. J. Clin. Pharmacol. (2001) 52(1):77-83.
10. DEMOLY P, BOUSQUET J: Epidemiology of drug allergy. Curr. Opin. Allergy Clin. Immunol. (2001) 1(4):305-310.
11. JOHANSSON SGO, BIEBER T, DAHL R, FRIEDMANN PS et al.: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. (2004) 113(5):832-836.
12. PICHLER WJ: Delayed drug hypersensitivity reactions. Ann. Intern. Med. (2003) 139(8):683-693.
13. RING J: Immunomodulation and the treatment of hives and eczema. World Allergy Forum Symposium: IgE and IgE receptors in allergic skin diseases. 61st AAAAI Annual Meeting, San Antonio, Texas, March 18, 2005.
14. STERN RS, BIGBY M: An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. J. Am. Med. Assoc. (1984) 252(11):1433-1437.
15. GOMES E, CARDOSO MF, PRAÇA F, GOMES L, MARIÑO E, DEMOLY P: Self-reported drug allergy in a general adult portuguese population. Clin. Exp. Allergy (2004) 34(10):1597-1601.
16. SETTIPANE GA. Aspirin and allergic diseases. Am. J. Med. (1983) 74(6A): 102-109.
17. STROM BL, CARSON JL, LEE MORSE M: The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal anti-inflammatory drugs. Arthritis Rheum. (1987) 30(10):1142-1148.
18. SANCHEZ-BORGES M, CAPRILES-HULETT A: Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann. Allergy Asthma Immunol. (2000) 84(1):101-106.
19. STEVENSON DD: Approach to the patient with a history of adverse reactions to aspirin or NSAIDs: Diagnosis and treatment. Allergy Asthma Proc. (2000) 21(1):25-31.
20. SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: NSAID-induced urticaria and angioedema. A reappraisal of its clinical management. Am. J. Clin. Dermatol. (2002) 3(9):599-607.
21. SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: Cutaneous reactions to aspirin and nonsteroidal anti-inflammatory drugs. Clin. Rev. Allergy Immunol. (2003) 24(2):125-136.
22. KWOH CK, FEINSTEIN AR: Rates of sensitivity reactions to aspirin: Problems in interpreting the data. Clin. Pharmacol. Ther. (1986) 40(5):494-505.
23. SZCZEKLIK A: The cyclooxygenase theory of aspirin-induced asthma. Eur. Respir. J. (1990) 3(5):588-593.
24. MASTALERZ L, SETKOWICZ M, SANAK M, SZCZEKLIK A: Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma. J. Allergy Clin. Immunol. (2004) 113(4):771-775.
25. QUIRALTE J, BLANCO C, CASTILLO R: Intolerame to nonsteroidal antiinflammatory drugs: results of controlled challenges in 98 patients. J. Allergy Clin. Immunol. (1996) 98(3):678-685.
26. ASERO R. Intolerance to nonsteroidal antiinflammatory drugs might precede by years the onset of chronic urticaria. J. Allergy Clin. Immunol. (2003) 111(5):1095-1098.
27. ASERO R, TEDESCHI A, LORINI M: Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Ann. Allergy Asthma Immunol. (2002) 88(5):468-472.
28. SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: The multiple faces of nonsteroidal anti-inflammatory drug hypersensitivity. J. Invest. Allergol. Clin. Immunol. (2004) 14(4):329-334.
29. SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: How safe are COX-2 inhibitors in NSAID-sensitive subjects with cutaneous reactions? Allergy Clin. Immunol. Int. (2003) 15(3):110-113.
30. SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: Adverse reactions to selective cyclooxygenase inhibitors (COXIBS). Am. J. Therap. (2004) 11(6):494-500.
31. NETTIS E, MARCANDREA M, FERRANNINI A, TURSI A: Tolerability of nimesulide and paracetamol in patients with NSAID-induced urticaria/angioedema. Immunopharmacol. Immunotoxicol. (2001) 23(3):343-354.
32. ISPANO M, FONTANA A, SCIBILIA J, ORTOLANI C: Oral challenge with alternative nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. Drugs (1993) 46(Suppl. 1):253-256.
33. PEREZ C, SANCHEZ-BORGES M, CAPRILES-HULETT A: Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J. Allergy Clin. Immunol. (2001) 108(6):1060-1061.
34. VAN DER KLAUW MM, WILSON JH, STRICKER BH: Drug-associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature. Clin. Exp. Allergy (1996) 26(12):1341-1342.
35. STROM BL, CARSON JL, SCHINNAR R, SIM E, LEE MORSE M: The effect of indication on the risk of hypersensitivity reactions associated with tolmetin sodium versus other nonsteroidal anti-inflammatory drugs. J. Rheumatol. (1988) 15(4):695-699.
36. TAKAHAMA H, KUBOTA Y, MIZOGUCHI M: A case of anaphylaxis due to ibuprofen. J. Dermatol. (2000) 27(5):337-340.
37. MENENDEZ R, VENZOR J, ORTIZ G: Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis. Ann. Allergy Asthma Immunol. (1998) 80(3):225-226.
38. CLENIN GE, VAN ROOIJEN MM, BRAATHEN LR: Ibuprofen-induzierte, transient ANA- und anti-histon positive leukozytoklastische vaskulitis. Der Hautarzt (2000) 51(9):678-681.
39. PETERS F, MAESSEN-VISCH B, KHO L: Leukocytoclastic vasculitis induced by a nonsteroidal antiinflammatory. J. Rheumatol. (1996) 23(11):2008-2009.
40. DAVIDSON KA, RINGPFEIL F, LEE JB: Ibuprofen-induced bullous leukocytoclastic vasculitis. Cutis (2001) 67(4):303-307.
41. SRIVASTAVA M, PEREZ-ATAYDE A, JONAS MM: Drug-associated acute-onset vanishing bile duct and Stevens-Johnson's syndromes in a child. Gastroenterology (1998) 115(3):743-746.
42. BERGNER T, PRZYBILLA B: Photosensitization caused by ibuprofen. J. Am. Acad Dermatol. (1992) 26(1):114-116.
43. KANWAR AJ, BELHAJ MS, BHARIJA SC, MOHAMMED M: Drugs causing fixed eruptions. J. Dermatol. (1984) 11(4):383-385.
44. MAHBOOB A, HAROON TS: Drugs causing fixed eruptions: A study of 450 cases. Int. J. Dermatol. (1998) 37(11):833-838.
45. KANWAR AJ, BHARIJA SC, SINGH M, BELHAJ MS: Ninety-eight fixed drug eruptions with provocation tests. Dermatologica (1988) 177(5):274-279.
46. KULIGOWSKI ME, CHANG A, RATH R: Multiple fixed drug eruption due to ibuprofen. Contact Dermatitis (1991) 25(4):259-260.
47. CORAZZA M, CAPOZZI O, VIRGILI A: Five cases of livedo-like dermatitis (Nicolau's syndrome) due to bismuth salts and various other non-steroidal anti-inflammatory drugs. J. Eur. Acad. Dermatol. Venereol. (2001) 15(6):585.
48. ALFONSO R, BELINCHON I: Linear drug eruption. Eur. J. Dermatol. (2001) 11(2):122-123.
49. KRASOWSKA D, SCHWARTZ RA, LECEWICZ-JORUN B: Generalized lichenoid drug eruption following Blaschko lines. Int. J. Dermatol. (2001) 40(12):774.
50. YESUDIAN PD, PENNY M, AZURDIA RM, KING CM: Ibuprofen-induced acute generalized exanthematous pustulosis. Int. J. Dermatol. (2004) 43(3):208.
51. ROUJEAU JC, Bioulac-SAGE P, BOURSEA C et al.: Acute generalized exanthematous pustulosis. Arch. Dermatol. (1991) 127(9):1333-1338.
52. GRATTAN LE: Generalized eruptive pustular drug rash due to naproxen. Dermatologica (1989) 179(1):57-58.
53. NETTIS E, GIORDANO D, COLANARDI MC, PARADISO MT, FERRANNINI A, TURSI A: Delayed-type hypersensitivity rash from ibuprofen. Allergy (2003) 58(6):539-540.
54. CIVATTE J: Drug-induced pemphigus diseases. Dermatol Monatsschr. (1989) 175(1):1-7.
55. FELLNER MJ: Drug-induced bullous pemphigoid. Clin. Dermatol. (1993) 11(4):515-520.
56. VERONESI S, DE PADOVA MP, BARDAZZI F, MELINO M: Contact dermatitis to ibuprofen. Contact Dermatitis (1986) 15(2):103-104.
57. VALSECCHI R, CAINELLI T: Contact dermatitis from ibuproxam. A case with cross-reactivity with ketoprofen. Contact Dermatitis (1990) 22(1):51.
58. SANCHEZ-BORGES M, CAPRILES-BEHRENS E, CABALLERO-FONSECA F: Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood. Pediatr. Allergy Immunol. (2004) 15(4):376-380.
59. SETTIPANE RA, CONSTANTINE HP, SETTIPANE GA: Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy (1980) 35(2):149-154.
60. LESKO SM, MITCHELL AM: An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. J. Am. Med. Assoc. (1995) 273(12):929-933.
61. LESKO SM, MITCHELL AM: The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics (1999) 104(4):c69.
62. CAPRILES-BEHRENS E, CAPLIN J, SANCHEZ-BORGES M: NSAID facial angioedema in a selected pediatric atopic population. J. Inv. Allergol. Clin. Immunol. (2000) 10(5):277-279.
63. DIAZ JARA M, PEREZ A, GRACIA MT, CABRERIZO S, ZAPATERO L, MARTINEZ MI: Allergic reactions due to ibuprofen in children. Pediatr. Dermatol. (2001) 18(1):66-67.